References
Di Micco B, Colonna D, Di Micco P, Di Micco G, Russo BM, Macalello MA, Ragone R (2003) Anti-thrombin action of low dose of acetylsalicilic acid. Eur J Pharmacol 406:59–62
Wallen NH, Ladjevardi M (1998) Influence of low and high dose aspirin treatment on thrombin generation in whole blood. Thromb Res 92:189–194
Herault JP, Dol F, Gaich C, Bernat A, Herbert JM (1999) Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat. Thromb Haemost 81:957–960
Theroux P, Waters D, Lam J, Juneau M, McCans J (1992) Reactivation of unstable angina after discontinuation of heparin. N Engl J Med 327:141–145
Fragmin During Instability in Coronary Artery Disease Study Group (1996) Low-molecular-weight-heparin during instability in coronary artery disease. Lancet 346:561–568
The Thrombin Inhibition in Myocardial Ischemia (TRIM) Study Group (1997) A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, for unstable coronary artery disease in 1209 patients. Eur Heart J 18:1416–1425
Hyers TM, Hull RD, Weg JG (1995) Antithrombotic therapy for thromboembolic disease. Chest 108[Suppl 4]:335S–351S
Caprie Steering Committee (1996) A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 9038:1329–1339
Caplain H, Donat F, Gaud C, Necciari J (1999) Pharmacokinetics of clopidogrel. Semin Thromb Hemost 25[Suppl 2]:25–28
Herbert JM, Savi P, Maffrand JP (1999) Biochemical and pharmacological properties of clopidogrel: a new ADP receptor antagonist. Eur Heart J Suppl 1[Suppl A]:A31–A40
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Di Micco, B., Di Micco, G., Niglio, A. et al. Proximal deep venous thrombosis occurring after sudden clopidogrel suspension. Eur J Clin Pharmacol 60, 63–64 (2004). https://doi.org/10.1007/s00228-003-0722-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-003-0722-z